Article

DMARD disruption, disease flare, and prolonged symptom duration after acute COVID-19 among participants with rheumatic disease: A prospective study

2022-02-09

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Objective</h4> To describe disease-modifying antirheumatic drug (DMARD) disruption, rheumatic disease flare/activity, and prolonged COVID-19 symptom duration among COVID-19 survivors with systemic autoimmune rheumatic diseases (SARDs). <h4>Methods</h4> We surveyed patients with SARDs after confirmed COVID-19 at Mass General Brigham to investigate post-acute sequelae of COVID-19. We obtained d...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a7031bbf-64f1-51be-92fb-a398a9ab358f
DOI: 10.1101/2022.02.08.22270696

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

DMARD disruption, disease flare, and prolonged symptom duration after acute COVID-19 among participants with rheumatic disease: A prospective studyDOI 10.1101/2022.02.08.22270696Read

Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: From the first wave to OmicronSemantic proximity Read

Clinical Features of Rheumatic Patients with Biologics Treatment Infected with COVID-19 in ChinaSemantic proximity Read

Risk of severe COVID-19 in patients with inflammatory rheumatic diseases treated with immunosuppressive therapy in ScotlandSemantic proximity Read

Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: A retrospective cohort studySemantic proximity Read

Incidence and management of inflammatory arthritis in England before and during the COVID-19 pandemic: a population-level cohort study using OpenSAFELYSemantic proximity Read

Covid 19 Infection in Patients with Rheumatic Immune-Mediated Diseases in a Single University Hospital. Matched Case-Control Study and Literature Review.Semantic proximity Read

Different Covid-19 Outcomes Among Systemic Rheumatic Diseases: A Nation-wide Cohort StudySemantic proximity Read

Assessment of Impact of the COVID-19 Pandemic from the Perspective of Patients with Rheumatic and Musculoskeletal Diseases in Europe: Results from the REUMAVID Study (Phase 1)Semantic proximity Read

How Did COVID-19 Pandemic Affect Rheumatology Out-Patients Practice? A Single-Center Experience from TurkeySemantic proximity Read

Does Biological Therapy Protect against Severe COVID-19?Semantic proximity Read

A Prospective Longitudinal Study Evaluating The Influence of Immunosuppressives and Other Factors On COVID-19 in Autoimmune Rheumatic DiseasesSemantic proximity Read

Biologic agents for rheumatic diseases in the break of COVID-19: friend or foe?Semantic proximity Read